| 发明名称 |
N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS |
| 摘要 |
The invention provides a compound of Formula (I);;or a pharmaceutically acceptable salt thereof; wherein
G is
;;R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal. |
| 申请公布号 |
US2015152109(A1) |
申请公布日期 |
2015.06.04 |
| 申请号 |
US201514621723 |
申请日期 |
2015.02.13 |
| 申请人 |
Pfizer Inc. |
发明人 |
Griffith David A.;Dow Robert L.;Bagley Scott W.;Smith Aaron |
| 分类号 |
C07D471/20 |
主分类号 |
C07D471/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A compound of structureor a pharmaceutically acceptable salt thereof. |
| 地址 |
New York NY US |
